Abstract
The vaccines currently in use against the SARS-CoV-2 coronavirus were developed based on both traditional processes and more modern technologies such as viral vectors and RNA-based vaccines. These new strategies were very effective and safe in clinical trials and have shown great efficiency in the control of COVID-19. These approaches take into account the presentation of important antige…